Filed before 2025Filed 4 December 2018
Paradigm Diagnostics, Inc. has sold $11M so far
Paradigm Diagnostics, Inc., a pharmaceuticals company based in Phoenix, AZ, has sold $11M so far in its equity round, according to a filing dated 4 December 2018.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 4 December 2018
- First filed
- 2 December 2016
- Round
- Equity round (amended filing)
- Amount sold
- $11M
- Offering size
- $12.5M
- Investors so far
- 12
- Based in
- Phoenix, AZ
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 65% of the 1,729 tracked raises with an amount filed in 2018, and than 48% of the 42 in pharmaceuticals.
Paradigm Diagnostics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 4 Dec 2018 | Amended filing | $11M | This raise |
| 3 Jul 2018 | Amended filing | $8.93M | This raise |
| 11 Dec 2017 | Amended filing | $7.4M | This raise |
More with Mesa Verde on the board
- Elysium Therapeutics, Inc.$2.23M
- MatriSys Bioscience, Inc.$8.4M
- ViaCyte Inc.$53.9M
- AltheaDx, Inc.$3.73M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.